Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Overweight 1Obesity 1

Interventions

Exercise 4Counseling 3Nutrition Assessment 2Naltrexone 2Metformin 2Exenatide 2Diet 2Cognitive Behavioral Therapy 2Caloric Restriction 2Bupropion 2sultamicillin 1licogliflozin 1drospirenone and ethinyl estradiol combination 1drospirenone 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1Tobacco Use Cessation Devices 1Surveys and Questionnaires 1Sugars 1Sucrose 1Standard of Care 1Resistance Training 1Psychology, Positive 1Propofol 1Motivational Interviewing 1Mindfulness-Based Stress Reduction 1Methods 1Flutamide 1Ethinyl Estradiol 1Diet, Mediterranean 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Overweight × Cyproterone × Clear all
NCT03151005 2023-12-04

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

Xinqiao Hospital of Chongqing

Phase 4 Completed
70 enrolled 11 charts
Other

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡